A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.
作者信息
Lancellotti Patrizio, Oury Cécile
机构信息
University of Liege Hospital, Liege, Belgium
出版信息
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
PMID:28471637
Abstract
摘要
相似文献
1
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9 RNAi治疗抑制剂。
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
2
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9的RNAi治疗抑制剂。
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
3
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9 RNAi治疗抑制剂。
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
4
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9 RNAi治疗抑制剂。
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
5
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.一种高度耐用的PCSK9 RNAi治疗抑制剂。
N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
6
Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.前蛋白转化酶枯草溶菌素 9 抑制：降低心血管疾病风险的新治疗机制。
Circulation. 2015 Oct 27;132(17):1648-66. doi: 10.1161/CIRCULATIONAHA.115.016080.
7
Targeting PCSK9 for the treatment of hypercholesterolemia.靶向前蛋白转化酶枯草溶菌素9治疗高胆固醇血症。
Curr Opin Investig Drugs. 2009 Sep;10(9):938-46.
8
An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo.针对 PCSK9 羧基末端结构域的抗体可降低体内 LDL 胆固醇水平。
J Mol Biol. 2014 Feb 20;426(4):843-52. doi: 10.1016/j.jmb.2013.11.011. Epub 2013 Nov 16.
9
Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.培养的平滑肌细胞分泌的前蛋白转化酶枯草溶菌素 9（PCSK9）降低巨噬细胞 LDLR 水平。
Atherosclerosis. 2012 Feb;220(2):381-6. doi: 10.1016/j.atherosclerosis.2011.11.026. Epub 2011 Nov 25.
10
PCSK9: a key modulator of cardiovascular health.PCSK9：心血管健康的关键调节因子。
Circ Res. 2014 Mar 14;114(6):1022-36. doi: 10.1161/CIRCRESAHA.114.301621.
引用本文的文献
1
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma.在成人T细胞白血病/淋巴瘤小鼠模型中用纳米疗法靶向核因子κB
Nanomaterials (Basel). 2021 Jun 16;11(6):1582. doi: 10.3390/nano11061582.
Zotero 插件